Top Legislation - View All
Also tagged in: Aged, Armed forces, Budgets, Case management, Centers for Disease Control and Prevention (CDC), Defense policy, Department of Health and Human Services, Drug abuse, Education, Executive departments, Executive reorganization, Federal advisory bodies, Federal aid to research, Federal officials, Government employees, Graduate education, Health policy, Health surveys, Higher education, Imaging systems in medicine, Lung cancer, Medicaid, Medical care, Medical education, Medical research, Medical screening, Medical statistics, Medical technology, Medical tests, Medicare, Medicine, Military medicine, Mortality, Pharmaceutical research, Quality of care, Research centers, Research grants, Science policy, Smoking, Surgery, Technology, Tobacco, Veterans, Veterans' medical care, Vital statistics, Welfare
Latest Action: 11/13/2007 - Mrs. Capps moved to suspend the rules and agree to the resolution, as amended. Bill TextExpressing the sense of the House of Representatives with respect to lung cancer as a public health priority and the recommendations of the Lung Cancer Progress Review Group of the National Cancer Institute. 11/13/2007--Passed House amended. (There is 1 other summary) Recognizes: (1) lung cancer as a public health priority; (2) the importance of reducing the lung cancer mortality rate by at least half by 2015; (3) the benefit of graduate medical education programs in thoracic medicine and cardiothoracic surgery; and (4) the importance of the recommendations of the Lung Cancer Progress Review Group of the National Cancer Institute. Encourages increased investment for lung cancer research and other lung cancer-related programs. Expresses support for efforts to develop a broad-based lung cancer screening and disease management program among members of the Armed Forces and veterans.
Also tagged in: Budgets, Cancer, Child health, Children, Clinical trials, Curricula, Education, Federal aid to research, Health education, Higher education, Medical care, Medical education, Medical research, Medicine, Pain, Pediatrics, Pharmaceutical research, Preventive medicine, Science policy
Latest Action: 09/05/2007 - Referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S11119) Bill TextA resolution supporting efforts to increase childhood cancer awareness, treatment, and research. 9/5/2007--Introduced. Calls for Congress to support: (1) efforts to promote awareness about the incidence, symptoms, and options for treatment of, and long-term follow-up for, cancer among children; (2) increased investment in childhood cancer research; (3) incentives to encourage medical trainees and investigators to enter the field of pediatric oncology; (4) incentives to encourage the development of drugs and biologics designed to treat pediatric cancers; (5) policies that encourage participation in clinical trials; (6) medical education curricula designed to improve pain management for cancer patients; and (7) enhanced education, services, and other resources related to late effects from treatment.
Also tagged in: Budgets, Cancer, Child health, Children, Clinical trials, Curricula, Education, Federal aid to research, Health education, Higher education, Medical care, Medical education, Medical research, Medicine, Pain, Pediatrics, Pharmaceutical research, Preventive medicine, Science policy
Latest Action: 09/25/2007 - Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent. (consideration: CR S12075-12076) Bill TextA resolution supporting efforts to increase childhood cancer awareness, treatment, and research. 9/25/2007--Passed Senate without amendment. (There is 1 other summary) (This measure has not been amended since it was introduced. The summary of that version is repeated here.) Calls for Congress to support: (1) efforts to promote awareness about the incidence, symptoms, and treatment options of cancer among children; (2) increased investment in childhood cancer research; (3) incentives to encourage medical trainees and investigators to enter the field of pediatric oncology; (4) incentives to encourage the development of drugs and biologics designed to treat pediatric cancers; (5) policies that encourage participation in clinical trials; (6) medical education curricula designed to improve pain management for cancer patients; (7) enhanced education, services, and other resources related to late effects from treatment; and (8) grassroots efforts [...] show full description
Also tagged in: Administrative procedure, Auditing, Business, Cancer, Child health, Children, Clinical trials, Communication in medicine, Communications, Congress, Congressional reporting requirements, Consumers, Data banks, Department of Health and Human Services, Drug advertising, Drug approvals, Drug industry, Executive departments, Fines (Penalties), Government information, Government paperwork, Government publicity, Governmental investigations, Health information systems, Identification devices, Law, Medical care, Medical instruments and apparatus, Medical research, Medical supplies, Medicine, National Institutes of Health (NIH), Nonprofit organizations, Periodicals, Product safety, Public contracts, Research centers, Science policy, Social services, Technology
Latest Action: 01/31/2007 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S1449-1454) Bill TextA bill to amend the Public Health Service Act to expand the clinical trials drug data bank. 1/31/2007--Introduced. Fair Access to Clinical Trials Act of 2007 or the FACT Act - Amends the Public Health Service Act to require the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health (NIH), to establish and operate a data bank of information on clinical trials, to include: (1) a clinical trials registry of health-related interventions conducted to test the safety or effectiveness of any drug, biological product, or device intended to treat serious or life-threatening diseases and conditions; and (2) a clinical trial results database of health-related interventions to test the safety or effectiveness of any drug, biological product, or device. Requires the Commissioner of Food and Drugs to make available to the public: (1) the full reviews conducted by the Food and Drug Administration (FDA) of new or supplemental new drug [...] show full description
Also tagged in: Budgets, Cancer, Child health, Children, Clinical trials, Curricula, Education, Federal aid to research, Health counseling, Health education, Higher education, Medical care, Medical education, Medical research, Medicine, Pediatrics, Pharmaceutical research, Preventive medicine, Science policy
Latest Action: 09/25/2007 - Mr. Pallone moved to suspend the rules and agree to the resolution. Bill TextSupporting efforts to increase childhood cancer awareness, treatment, and research. 9/25/2007--Passed House without amendment. (There is 1 other summary) (This measure has not been amended since it was introduced. The summary of that version is repeated here.) Calls for Congress to support: (1) efforts to promote awareness about the incidence, symptoms, and treatment options of cancer among children; (2) increased investment in childhood cancer research; (3) incentives to encourage medical trainees and investigators to enter the field of pediatric oncology; (4) incentives to encourage the development of drugs and biologics designed to treat pediatric cancers; (5) policies that encourage participation in clinical trials; (6) medical education curricula designed to improve pain management for cancer patients; and (7) enhanced education, services, and other resources related to late effects from treatment.
Also tagged in: AIDS (Disease), Congress, Congress and foreign policy, Congressional reporting requirements, Drug resistance in microorganisms, Drugs, Economic assistance, Foreign aid, Foreign policy, Health policy, Human immunodeficiency viruses, International affairs, International agencies, Medical care, Medical records, Medical research, Medical tests, Medicine, Pharmaceutical research, President and foreign policy, Presidents, Public health, Quality of care, Science policy, Standards, Tuberculosis, Vaccines, World health
Latest Action: 10/09/2007 - Committee on Foreign Relations. Reported by Senator Biden under authority of the order of the Senate of 10/04/2007 with an amendment in the nature of a substitute. With written report No. 110-193. Bill TextA bill to amend the Foreign Assistance Act of 1961 to provide increased assistance for the prevention, treatment, and control of tuberculosis, and for other purposes. 10/9/2007--Reported to Senate amended. (There is 1 other summary) Stop Tuberculosis (TB) Now Act of 2007 - Amends the Foreign Assistance Act of 1961 to require the President to furnish assistance for tuberculosis (TB) prevention, treatment, and elimination.(Current law authorizes such assistance.) Gives priority to activities described in the Stop TB Strategy (as defined by this Act). Revises related fund use provisions. Authorizes the President, through the United States Agency for International Development (USAID), to provide increased resources to the World Health Organization (WHO) and the Stop Tuberculosis Partnership to improve the capacity of countries with high TB rates and other affected countries to implement the Stop TB Strategy and specific strategies related [...] show full description
Also tagged in: Access to health care, Aged, Biomedical engineering, Budgets, Cancer, Case management, Children, Clinical trials, Colon cancer, Congress, Congressional reporting requirements, Continuum of care, Department of Health and Human Services, Drug abuse, Drug approvals, Education, Environmental health, Environmental protection, Executive departments, Federal advisory bodies, Federal aid to child health services, Federal aid to health facilities, Federal aid to research, Genetic research, Governmental investigations, Health planning, Health policy, Higher education, Imaging systems in medicine, Intellectual property, Lung cancer, Medical care, Medical education, Medical instruments and apparatus, Medical research, Medical screening, Medical supplies, Medical technology, Medicare, Medicine, Minorities, Minority health, National Institutes of Health (NIH), Nursing, Patents, Pharmaceutical research, Preventive medicine, Quality of care, Quality of life, Research centers, Scholarships, Science policy, Smoking, Strategic planning, Student loan funds, Technology, Tissue banks
Latest Action: 03/29/2007 - Sponsor introductory remarks on measure. (CR S4188) Bill TextA bill to provide for a comprehensive Federal effort relating to early detection of, treatments for, and the prevention of cancer, and for other purposes. 3/29/2007--Introduced. National Cancer Act of 2007 - Amends the Public Health Service Act to require the Director of the National Cancer Institute to establish a loan repayment program for health professionals agreeing to engage in cancer prevention research. Provides for research on cancer treatments that target cancer cells, the cancer care workforce, cancer survivorship, environmental risk factors for cancer, and treatment disparities.Requires the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to carry out demonstration programs on: (1) lung cancer early detection using Computer Tomography (CT) scanning; and (2) colorectal screening.Amends the Federal Food, Drug, and Cosmetic Act to set forth provisions for chemoprevention [...] show full description
Also tagged in: Abortion, Actions and defenses, Administrative fees, Administrative procedure, Agriculture, Agriculture in foreign trade, Animals, Antibiotics, Biomedical engineering, Budgets, Business, Canada, Cancer, Child health, Children, Clinical trials, Communicable diseases, Communication in medicine, Communications, Conflict of interests, Congress, Congressional investigations, Congressional oversight, Congressional reporting requirements, Consumer education, Consumers, Cosmetics, Counterfeiting, Criminal justice, Data banks, Defective products, Department of Health and Human Services, Drug abuse, Drug adulteration, Drug approvals, Drug industry, Drug interactions, Drug law enforcement, Drug therapy, Drug utilization, Drugs, Education, Electronic data interchange, Elementary and secondary education, Environmental protection, Executive departments, Eye diseases, Families, Federal advisory bodies, Federal aid to education, Federal aid to research, Federal reserve system, Fines (Penalties), Food, Food additives, Food and Drug Administration (FDA), Food industry, Food preservation, Food safety, Food supply, Foodborne diseases, Foundations, Fraud, Generic drugs, Genetic counseling, Genetic engineering, Genetics, Government information, Government paperwork, Government publicity, Hazardous substances, Health information systems, Health surveys, Health warnings, Higher education, Imaging systems in medicine, Import restrictions, Intellectual property, Internet, Labeling, Law, Marijuana, Meat, Medical care, Medical education, Medical instruments and apparatus, Medical laboratories, Medical records, Medical statistics, Medical supplies, Medicinal plants, Medicine, Orphan drugs, Packaging, Parent and child, Parental consent, Patent infringement, Pediatrics, Pesticides, Pets, Pharmaceutical research, Pharmacists, Physical examinations, Politics and government, Preschool education, Prescription pricing, Prices, Produce trade, Product development, Product safety, Protection of animals, Public meetings, Research and development, Research grants, Restrictive trade practices, Risk, Salmonella, Scholarships, Science policy, Seafood, Shellfish, Skin cancer, Skin diseases, Small business, Social services, Strategic planning, Student loan funds, Technology, Telecommunication, Trade, Turtles, User charges, Web sites
Latest Action: 05/10/2007 - Received in the House. Bill TextAn act to amend the Federal Food, Drug, and cosmetic Act and the Public Health Service Act to reauthorize drug and device user fees and ensure the safety of medical products, and for other purposes. 5/9/2007--Passed Senate amended. (There are 2 other summaries) Food and Drug Administration Revitalization Act - Title I: Prescription Drug User Fees - (Sec. 101) - Prescription Drug User Fee Amendments of 2007 - (Sec. 102) Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to set forth as a purpose that authorized prescription drug fees be dedicated toward expediting the drug development process, the process for the review of human drug applications, and postmarket drug safety. Sets forth reporting requirements, including requiring the Secretary of Human Services (the Secretary) to present to Congress recommendations developed for achieving certain goals for the review process of human drug applications and for reauthorization of user [...] show full description
Also tagged in: Aged, Cancer, Drugs, Health policy, Medical care, Medical fees, Medicare, Medicine, Pharmacies, Physicians, Prescription pricing
Latest Action: 03/07/2007 - Referred to the Subcommittee on Health. Bill TextTo amend title XVIII of the Social Security Act to preserve access to community cancer care by Medicare beneficiaries. 2/27/2007--Introduced. Community Cancer Care Preservation Act of 2007 - Amends title XVIII (Medicare) of the Social Security Act to require determination and calculation of the manufacturer's average sales price for a drug or biological on a monthly instead of a quarterly basis. Requires the payment amounts to be updated and applied by the Secretary of Health and Human Services based on the manufacturer's average sales price for the drug or biological calculated for the most recent month for which data are available. Removes prompt pay discounts from the calculation of such price. Provides for an increase in the Medicare part B (Supplementary Medical Insurance) payment for chemotherapy administration services. Directs the Secretary to make an additional 2% for any drug administration services payment to physicians, taking into account pharmacy [...] show full description
Also tagged in: Access to health care, Administrative remedies, Admission of nonimmigrants, Advice and consent of the Senate, Aged, AIDS (Disease), Alcoholism, Aliens, Ambulances, Ambulatory care, Anesthetics, Armed forces, Birth control, Block grants, Budgets, Business, Capital budgets, Capitation (Medical care), Case management, Case mix (Medical care), Child health, Children, Chronically ill, Cigarettes, Civil rights, Communicable diseases, Communication in medicine, Communications, Community health services, Community organization, Competitive bidding, Comprehensive health care, Computer software, Computers, Congress, Congressional reporting requirements, Consumer complaints, Consumer organizations, Consumer price indexes, Consumers, Cost control, Cost effectiveness, Criminal investigation, Criminal justice, Data banks, Defense policy, Dental care, Dentistry, Department of Health and Human Services, Disability insurance, Disabled, Discrimination in insurance, Discrimination in medical care, Dislocated workers, Drug abuse, Drug abuse prevention, Drug abuse treatment, Drug approvals, Drug industry, Drug therapy, Drug utilization, Drugs, Economic policy, Education, Electronic data interchange, Electronic government information, Elementary and secondary education, Emergency management, Emergency medicine, Employee health benefits, Environmental health, Environmental protection, Excise tax, Executive departments, Executive reorganization, Families, Family medicine, Federal advisory bodies, Federal aid to child health services, Federal aid to education, Federal aid to health facilities, Federal aid to research, Federal employees, Federal preemption, Finance, Fines (Penalties), Food, Food safety, Foodborne diseases, Free ports and zones, Government employees, Government employees' health insurance, Government information, Government paperwork, Government publicity, Government trust funds, Grievance procedures, Gynecology, Hazardous substances, Health care fraud, Health education, Health facilities, Health insurance, Health insurance continuation, Health insurance portability, Health planning, Health policy, Health services administration, Higher education, Home care services, Hospital care, Hospital personnel, Hospitals, Human immunodeficiency viruses, Identification devices, Immigration, Income tax, Inspectors general, Insurance premiums, Interstate relations, Job training, Labor, Labor unions, Law, Licenses, Long-term care insurance, Maternal health services, Medicaid, Medical care, Medical economics, Medical education, Medical ethics, Medical fees, Medical instruments and apparatus, Medical laboratories, Medical malpractice, Medical research, Medical residents, Medical screening, Medical statistics, Medical supplies, Medical technology, Medical tests, Medically uninsured, Medicare, Medicine, Mental health services, Midwives, Military dependents, Military medicine, Nonprofit organizations, Nurse practitioners, Nurses, Nursing education, Nursing homes, Nutrition, Obstetrics, Occupational health and safety, Ombudsman, Patients' rights, Pediatrics, Pharmacies, Pharmacists, Physicians, Physicians' assistants, Politics and government, Potable water, Prescription pricing, Presidential appointments, Presidents, Preventive medicine, Product safety, Prosecution, Public contracts, Public health, Public health personnel, Quality of care, Railroad employees, Regional medical programs, Research centers, Rural affairs, Rural health, School health programs, Science policy, Sexually transmitted diseases, Smokeless tobacco, Social services, Standards, State and local government, State budgets, State politics and government, Tax credits, Tax rates, Taxation, Technology, Telecommunication, Tobacco tax, Trade, Transportation, Tuberculosis, Urban affairs, Vending machines, Violence, Vital statistics, Vocational rehabilitation, Water pollution, Water quality, Water resources, Welfare, Welfare fraud, Women
Latest Action: 04/24/2007 - Sponsor introductory remarks on measure. (CR H4034-4035) Bill TextTo provide for health care for every American and to control the cost and enhance the quality of the health care system. 2/27/2007--Introduced. American Health Security Act of 2007 - Establishes the State-Based American Health Security Program to provide every U.S. resident who is a U.S. citizen, national, or lawful resident alien with health care services. Requires each participating state to establish a state health security program. Eliminates benefits under: (1) titles XVIII (Medicare), XIX (Medicaid), and XXI (State Children's Health Insurance) (SCHIP) of the Social Security Act; (2) the Federal Employees Health Benefits Program; and (3) the Civilian Health and Medical Program of the Uniformed Services (CHAMPUS). Requires each state health security program to prohibit the sale of health insurance in that state that duplicates benefits provided under the program. Establishes the American Health Security Standards Board to: (1) develop policies,[...] show full description
|
Latest Legislation - View All
Also tagged in: Access to health care, Armed forces, Budgets, Carcinogens, Defense policy, Drug abuse, Executive departments, Federal advisory bodies, Federal aid to research, Health policy, Lung cancer, Medical care, Medical research, Medical tests, Medicine, Military medicine, Minorities, Minority health, Mortality, Nicotine, Pharmaceutical research, Preventive medicine, Research grants, Science policy, Smoking, Surgery, Vaccines, Veterans, Veterans' medical care
Latest Action: 06/25/2008 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Bill TextA bill to establish a comprehensive interagency response to reduce lung cancer mortality in a timely manner. 6/25/2008--Introduced. Lung Cancer Mortality Reduction Act of 2008 - Amends the Public Health Service Act to require the Secretary of Health and Human Services (the Secretary) to implement a comprehensive program to achieve a 50% reduction in the mortality rate of lung cancer by 2015. Includes within such program: (1) a strategic review and prioritization of research grants; (2) an expansion of research programs, such as on predispositions to lung cancer; and (3) the expedited development of computer assisted diagnostic, surgical, treatment, and drug testing innovations.Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary to provide incentives for the development of chemoprevention drugs for precancerous conditions of the lung, drugs for targeted therapeutic treatments and vaccines for lung cancer, and new agents to curtail or prevent nicotine [...] show full description
Also tagged in: Administrative procedure, Aged, Blood diseases, Cancer, Department of Health and Human Services, Drugs, Executive departments, Health policy, Law, Medicaid, Medical care, Medicare, Medicine, Welfare
Latest Action: 11/08/2007 - Referred to the Subcommittee on Health. Bill TextTo express the sense of the House of Representatives regarding the Medicare national coverage determination on the treatment of anemia in cancer patients. 9/25/2007--Introduced. Expresses the sense of the House of Representatives that the Centers for Medicare and Medicaid Services should: (1) begin an immediate reconsideration of the final National Coverage Determination on the Use of Erythropoiesis Stimulating Agents in Cancer and Related Neoplastic Conditions; (2) consult with members of the clinical oncology community to determine appropriate revisions to such Determination; and (3) implement appropriate revisions to such Determination as soon as feasible and provide a briefing to Congress in advance of announcing such changes.
Also tagged in: Budgets, Cancer, Child health, Children, Clinical trials, Curricula, Education, Federal aid to research, Health education, Higher education, Medical care, Medical education, Medical research, Medicine, Pain, Pediatrics, Pharmaceutical research, Preventive medicine, Science policy
Latest Action: 09/25/2007 - Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent. (consideration: CR S12075-12076) Bill TextA resolution supporting efforts to increase childhood cancer awareness, treatment, and research. 9/25/2007--Passed Senate without amendment. (There is 1 other summary) (This measure has not been amended since it was introduced. The summary of that version is repeated here.) Calls for Congress to support: (1) efforts to promote awareness about the incidence, symptoms, and treatment options of cancer among children; (2) increased investment in childhood cancer research; (3) incentives to encourage medical trainees and investigators to enter the field of pediatric oncology; (4) incentives to encourage the development of drugs and biologics designed to treat pediatric cancers; (5) policies that encourage participation in clinical trials; (6) medical education curricula designed to improve pain management for cancer patients; (7) enhanced education, services, and other resources related to late effects from treatment; and (8) grassroots efforts [...] show full description
Also tagged in: Budgets, Cancer, Child health, Children, Clinical trials, Curricula, Education, Federal aid to research, Health education, Higher education, Medical care, Medical education, Medical research, Medicine, Pain, Pediatrics, Pharmaceutical research, Preventive medicine, Science policy
Latest Action: 09/05/2007 - Referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S11119) Bill TextA resolution supporting efforts to increase childhood cancer awareness, treatment, and research. 9/5/2007--Introduced. Calls for Congress to support: (1) efforts to promote awareness about the incidence, symptoms, and options for treatment of, and long-term follow-up for, cancer among children; (2) increased investment in childhood cancer research; (3) incentives to encourage medical trainees and investigators to enter the field of pediatric oncology; (4) incentives to encourage the development of drugs and biologics designed to treat pediatric cancers; (5) policies that encourage participation in clinical trials; (6) medical education curricula designed to improve pain management for cancer patients; and (7) enhanced education, services, and other resources related to late effects from treatment.
Also tagged in: Aged, Cancer, Drugs, Health policy, Medical care, Medical fees, Medicare, Medicine, Pharmacies, Physicians, Prescription pricing
Latest Action: 07/09/2007 - Sponsor introductory remarks on measure. (CR S8797-8798) Bill TextA bill to amend title XVIII of the Social Security Act to preserve access to community cancer care by Medicare beneficiaries. 7/9/2007--Introduced. Community Cancer Care Preservation Act of 2007 - Amends title XVIII (Medicare) of the Social Security Act to require determination and calculation of the manufacturer's average sales price for a drug or biological on a monthly instead of a quarterly basis. Requires the payment amounts to be updated and applied by the Secretary of Health and Human Services based on the manufacturer's average sales price for the drug or biological calculated for the most recent month for which data are available. Removes prompt pay discounts from the calculation of such price.Provides for an increase in the Medicare part B (Supplementary Medical Insurance) payment for chemotherapy administration services.Directs the Secretary to make an additional 2% for any drug administration services payment to physicians, taking into account pharmacy [...] show full description
Also tagged in: Access to health care, Bone diseases, Business, Civil liberties, Civil rights, Coinsurance, Communication in medicine, Communications, Discrimination in insurance, Discrimination in medical care, Drug therapy, Employee health benefits, Estrogen, Finance, Freedom of speech, Government information, Government paperwork, Health insurance, Health policy, Imaging systems in medicine, Insurance companies, Labor, Medical care, Medical tests, Medicine, Osteoporosis, Patients' rights, Physician-patient privilege, Preventive medicine, Radioisotopes in medicine, State and local government, State laws, Steroids, Technology, Thyroid diseases, Women, Women's health, Women's health services, X-rays
Latest Action: 09/11/2007 - Referred to the Subcommittee on Health, Employment, Labor, and Pensions. Bill TextTo amend the Public Health Service Act and Employee Retirement Income Security Act of 1974 to require that group and individual health insurance coverage and group health plans provide coverage for qualified individuals for bone mass measurement (bone density testing) to prevent fractures associated with osteoporosis. 6/28/2007--Introduced. Osteoporosis Early Detection and Prevention Act of 2007 - Amends the Public Health Service Act and the Employee Retirement Income Security Act of 1974 (ERISA) to require a group health plan to include coverage for bone mass measurement for individuals who: (1) are at a clinical risk for osteoporosis, including estrogen-deficient women; (2) have vertebral abnormalities; (3) are receiving chemotherapy or long-term gluococorticoid (steroid) therapy; (4) have primary hyperparathyroidism, hyperthyroidism, or excess thyroid replacement; or (5) are being monitored to assess the response to or efficacy of approved osteoporosis drug therapy. Requires [...] show full description
Also tagged in: Budgets, Business, Cancer, Child health, Children, Clinical trials, Education, Families, Federal aid to research, Health counseling, Health education, Higher education, Medical care, Medical education, Medical research, Medicine, Pediatrics, Pharmaceutical research, Preventive medicine, Public-private partnerships, Quality of life, Science policy
Latest Action: 06/25/2007 - Referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S8364-8365) Bill TextA resolution supporting efforts for increased healthy living for childhood cancer survivors. 6/25/2007--Introduced. Calls for the U.S government to: (1) support neuropsychological research and testing of childhood cancer survivors and their families; (2) work with health care providers, educators, and childhood cancer advocacy and education organizations to encourage such testing; (3) reaffirm the U.S. commitment to fighting childhood cancer by promoting awareness about its causes, risks, prevention, and treatment; (4) promote new education programs about, research of, and expanded medical treatment for childhood cancer survivors; (5) support research and expanded public-private partnerships to improve post-cancer life for survivors; and (6) encourage early diagnosis and access to high-quality care for childhood cancer patients and survivors.
Also tagged in: Budgets, Cancer, Child health, Children, Clinical trials, Curricula, Education, Federal aid to research, Health counseling, Health education, Higher education, Medical care, Medical education, Medical research, Medicine, Pediatrics, Pharmaceutical research, Preventive medicine, Science policy
Latest Action: 09/25/2007 - Mr. Pallone moved to suspend the rules and agree to the resolution. Bill TextSupporting efforts to increase childhood cancer awareness, treatment, and research. 9/25/2007--Passed House without amendment. (There is 1 other summary) (This measure has not been amended since it was introduced. The summary of that version is repeated here.) Calls for Congress to support: (1) efforts to promote awareness about the incidence, symptoms, and treatment options of cancer among children; (2) increased investment in childhood cancer research; (3) incentives to encourage medical trainees and investigators to enter the field of pediatric oncology; (4) incentives to encourage the development of drugs and biologics designed to treat pediatric cancers; (5) policies that encourage participation in clinical trials; (6) medical education curricula designed to improve pain management for cancer patients; and (7) enhanced education, services, and other resources related to late effects from treatment.
Also tagged in: Aged, Armed forces, Budgets, Case management, Centers for Disease Control and Prevention (CDC), Defense policy, Department of Health and Human Services, Drug abuse, Education, Executive departments, Executive reorganization, Federal advisory bodies, Federal aid to research, Federal officials, Government employees, Graduate education, Health policy, Health surveys, Higher education, Imaging systems in medicine, Lung cancer, Medicaid, Medical care, Medical education, Medical research, Medical screening, Medical statistics, Medical technology, Medical tests, Medicare, Medicine, Military medicine, Mortality, Pharmaceutical research, Quality of care, Research centers, Research grants, Science policy, Smoking, Surgery, Technology, Tobacco, Veterans, Veterans' medical care, Vital statistics, Welfare
Latest Action: 11/13/2007 - Mrs. Capps moved to suspend the rules and agree to the resolution, as amended. Bill TextExpressing the sense of the House of Representatives with respect to lung cancer as a public health priority and the recommendations of the Lung Cancer Progress Review Group of the National Cancer Institute. 11/13/2007--Passed House amended. (There is 1 other summary) Recognizes: (1) lung cancer as a public health priority; (2) the importance of reducing the lung cancer mortality rate by at least half by 2015; (3) the benefit of graduate medical education programs in thoracic medicine and cardiothoracic surgery; and (4) the importance of the recommendations of the Lung Cancer Progress Review Group of the National Cancer Institute. Encourages increased investment for lung cancer research and other lung cancer-related programs. Expresses support for efforts to develop a broad-based lung cancer screening and disease management program among members of the Armed Forces and veterans.
Also tagged in: Abortion, Actions and defenses, Administrative fees, Administrative procedure, Agriculture, Agriculture in foreign trade, Animals, Antibiotics, Biomedical engineering, Budgets, Business, Canada, Cancer, Child health, Children, Clinical trials, Communicable diseases, Communication in medicine, Communications, Conflict of interests, Congress, Congressional investigations, Congressional oversight, Congressional reporting requirements, Consumer education, Consumers, Cosmetics, Counterfeiting, Criminal justice, Data banks, Defective products, Department of Health and Human Services, Drug abuse, Drug adulteration, Drug approvals, Drug industry, Drug interactions, Drug law enforcement, Drug therapy, Drug utilization, Drugs, Education, Electronic data interchange, Elementary and secondary education, Environmental protection, Executive departments, Eye diseases, Families, Federal advisory bodies, Federal aid to education, Federal aid to research, Federal reserve system, Fines (Penalties), Food, Food additives, Food and Drug Administration (FDA), Food industry, Food preservation, Food safety, Food supply, Foodborne diseases, Foundations, Fraud, Generic drugs, Genetic counseling, Genetic engineering, Genetics, Government information, Government paperwork, Government publicity, Hazardous substances, Health information systems, Health surveys, Health warnings, Higher education, Imaging systems in medicine, Import restrictions, Intellectual property, Internet, Labeling, Law, Marijuana, Meat, Medical care, Medical education, Medical instruments and apparatus, Medical laboratories, Medical records, Medical statistics, Medical supplies, Medicinal plants, Medicine, Orphan drugs, Packaging, Parent and child, Parental consent, Patent infringement, Pediatrics, Pesticides, Pets, Pharmaceutical research, Pharmacists, Physical examinations, Politics and government, Preschool education, Prescription pricing, Prices, Produce trade, Product development, Product safety, Protection of animals, Public meetings, Research and development, Research grants, Restrictive trade practices, Risk, Salmonella, Scholarships, Science policy, Seafood, Shellfish, Skin cancer, Skin diseases, Small business, Social services, Strategic planning, Student loan funds, Technology, Telecommunication, Trade, Turtles, User charges, Web sites
Latest Action: 05/10/2007 - Received in the House. Bill TextAn act to amend the Federal Food, Drug, and cosmetic Act and the Public Health Service Act to reauthorize drug and device user fees and ensure the safety of medical products, and for other purposes. 5/9/2007--Passed Senate amended. (There are 2 other summaries) Food and Drug Administration Revitalization Act - Title I: Prescription Drug User Fees - (Sec. 101) - Prescription Drug User Fee Amendments of 2007 - (Sec. 102) Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to set forth as a purpose that authorized prescription drug fees be dedicated toward expediting the drug development process, the process for the review of human drug applications, and postmarket drug safety. Sets forth reporting requirements, including requiring the Secretary of Human Services (the Secretary) to present to Congress recommendations developed for achieving certain goals for the review process of human drug applications and for reauthorization of user [...] show full description
|
